Learn More
Medchemexpress LLC Methyl (4-((4-fluorobenzyl)(prop-2-yn-1-yl)amino)-2,6-dimethylphenyl)carbamate | 1821222-10-9 | MFCD34676457 | 99.5% | C20H21FN2O2 | 10MG

Supplier: Medchemexpress LLC HY14501610MG
HN37 is a small-molecule KCNQ2 (Kv7) activator intended for laboratory research use. It exhibits potent neuronal Kv7 activation with reported antiepileptic activity (EC50 ≈ 37 nM) and contains an alkyne functional group that enables copper-catalyzed azide-alkyne cycloaddition (CuAAC) for bioconjugation and probe synthesis. The compound is provided as a high-purity solid or DMSO solution for experimental use.
- Potent KCNQ2 (Kv7) activator with EC50 ≈ 37 nM.
- Contains an alkyne group for CuAAC click chemistry.
- High purity (99.53%) suitable for research applications.
- Supplied in solid and DMSO solution formats.
- Intended for laboratory research only; not for human use.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.